Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/AIDS cohort study, 2006 to 2013-Reference-Cited by-同舟云学术

Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/AIDS cohort study, 2006 to 2013

Published:2016-09-01 Issue:5 Volume:31 Page:953-960
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim Youn Jeong,Woo Jun Hee,Kim Min Ja,Park Dae Won,Song Joon-Young,Kim Shin Woo,Choi Jun Yong,Kim June Myung,Han Sang Hoon,Lee Jin-Soo,Choi Bo Youl,Lee Joo Shil,Kim Sung-Soon,Kee Mee-Kyung,Kang Moon Won,Kim Sang Il

Funder

Korea Centers for Disease Control and Prevention

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2014-322.pdf

Reference23 articles.

1. AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study

2. Declining incidence of AIDS-defining opportunistic illnesses

3. Epidemiology and Clinical Features of HIV Infection/AIDS in Korea

4. Spectrum of Opportunistic Infections and Malignancies in Patients with Human Immunodeficiency Virus Infection in South Korea

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of extrapulmonary tuberculosis among people living with HIV/AIDS in Southeast Asia: a systematic review and meta-analysis;Monaldi Archives for Chest Disease;2024-07-23

2. Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list;Medical Mycology;2024-06

3. AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999–2018;Infection;2024-02-21

4. Alkaloids as Potential Anti-HIV Agents;Current HIV Research;2023-07

5. Rate of and Risk Factors for Loss to Follow Up in HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study;Infection & Chemotherapy;2023